CAJ | 학술논문

目的研究脑卒中患者焦虑和抑郁性障碍的发生率和治疗效果。方法用汉密尔顿焦虑量表(HAMA)和抑郁量表(HAMD)评估86例脑卒中病人，对伴有焦虑、抑郁性障碍者，用苯二氮萆类、氟西汀、万拉法新治疗。结果86例患者中，焦虑、抑郁性障碍的发生率分别为48.8％、38.4％，治疗好转率分别为83.3％、75.8％。治疗后HAMA和HAMD积分较治疗前明显减少(P＜0.01)。结论焦虑、抑郁性障碍在脑卒中患者中的发生率高，抗焦虑、抑郁治疗的疗效显著。
목적연구뇌졸중환자초필화억욱성장애적발생솔화치료효과。방법용한밀이돈초필량표(HAMA)화억욱량표(HAMD)평고86례뇌졸중병인，대반유초필、억욱성장애자，용분이담비류、불서정、만랍법신치료。결과86례환자중，초필、억욱성장애적발생솔분별위48.8％、38.4％，치료호전솔분별위83.3％、75.8％。치료후HAMA화HAMD적분교치료전명현감소(P＜0.01)。결론초필、억욱성장애재뇌졸중환자중적발생솔고，항초필、억욱치료적료효현저。
Objective To study the frequencies and therapeutic effect of anxious and depressive disorders in patients with stroke. Methods 86 patients were assessed with Hamilton anxiety scale(HAMA)and Hamilton depression scale (HAMD). The patients with anxious and depressive disorders were treated with antianxiety agents and antidepressants such as benzodiazepines, fluoxetine, and venlafaxine. Results In the 86 patients, the frequencies of anxious and depressive disorders were 48.8%, 38.4%, respectively, recovery rates of treatment were 83.3%, 75.8%, respectively, in which the scores of HAMA and HAMD after treatment were much less than that before treatment( P ＜0.01). Conclusion The frequencies of anxious and depressive disorders in patients with stroke are very high, and the apparent effect of antianxiety agents and antidepressants are observed.